Transjugular Thrombolysis and Stent-Graft Implantation for Acute Portal Vein Aneurysm Thrombosis

Wannhoff, Andreas; Riecken, Bettina; Caca, Karel

doi:10.1016/j.jvir.2023.03.013

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Portal vein stenting is a treatment option for portal hypertension caused by EHPVO or EHPVS [ 5 ]. Portal vein stenting is performed via a percutaneous transhepatic approach, laparotomy via the transileocolic vein, or a transjugular intrahepatic portosystemic route [ 6 , 7 ]. Additionally, liver abscesses, intraperitoneal bleeding, bile duct injuries, and biliary bleeding have been reported using the percutaneous transhepatic approach [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

First Experience With the Utility of ReMAP (Repeatable Microcatheter Access Port) in Portal Vein Stenting

Fujimoto,

Kondo,

Unozawa

et al. 2024

Cureus

View full text Add to dashboard Cite

Portal vein stenting is a treatment option for portal hypertension caused by extrahepatic portal vein obstruction or stenosis. However, limited pathways to approach the portal vein are available, hindering re-intervention in the portal vein. Portal vein puncture through the transjugular intrahepatic portosystemic shunt route is less invasive and considered suitable for portal vein stenting. Furthermore, transjugular intrahepatic portosystemic shunting facilitates repeat approaches to the portal vein. However, a transjugular intrahepatic portosystemic shunt stent is not recommended unless necessary because of adverse events, and cannot be retrieved, once placed. Herein, we report on a novel approach using the repeatable microcatheter access port: ReMAP™ (Toray, Tokyo, Japan), a central vein port into which a 2.9 Fr catheter can be inserted. We used it for a repeat approach to the portal vein with only one puncture and without placing a transjugular intrahepatic portosystemic shunt stent.

show abstract